Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9340830 Optimization of multigene analysis of tumor samples

Patent 9340830 was granted and assigned to Foundation Medicine on May, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Foundation Medicine
Foundation Medicine
Date Filed
December 29, 2011
Date of Patent
May 17, 2016
Patent Application Number
13339986
Patent Citations Received
‌
US Patent 12116624 Systems and methods to detect rare mutations and copy number variation
0
‌
US Patent 12018252 Methods and compositions for identifying neoantigens for use in treating cancer
0
‌
US Patent 12018336 Methods for sequencing samples
0
‌
US Patent 12025615 Methods of classifying response to immunotherapy for cancer
0
‌
US Patent 12024745 Methods and systems for detecting genetic variants
0
‌
US Patent 12024746 Methods and systems for detecting genetic variants
0
‌
US Patent 12094573 Methods for multi-resolution analysis of cell-free nucleic acids
0
‌
US Patent 12109257 Alphavirus neoantigen vectors
0
‌
US Patent 12110560 Methods for monitoring residual disease
0
‌
US Patent 11753674 Methods and systems for determining spatial patterns of biological targets in a sample
•••
Patent Inventor Names
Mikhail G. Shapiro
0
Alexander N. Parker
0
Doron Lipson
0
Geoffrey Alan Otto
0
Mima Jarosz
0
Philip James Stephens
0
Roman Yelensky
0
Sean R. Downing
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9340830
Patent Primary Examiner
‌
Larry D Riggs, II

Find more entities like US Patent 9340830 Optimization of multigene analysis of tumor samples

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.